Literature DB >> 22846726

Guillain-Barré syndrome incidence in a large United States cohort (2000-2009).

Irene M Shui1, Melisa D Rett, Eric Weintraub, Michael Marcy, Anthony A Amato, Sarah I Sheikh, Doreen Ho, Grace M Lee, W Katherine Yih.   

Abstract

BACKGROUND/AIM: We describe the incidence of Guillain-Barré syndrome (GBS) in a large United States cohort.
METHODS: Between 2000 and 2009, we identified visits with an ICD-9 code for GBS (357.0) from all persons with continuous enrollment for at least 1 year. The primary case definition was restricted to emergency department and inpatient visits. We calculated age-standardized rates and used multivariate Poisson regression to assess variation in rates by sex, age, season and year of diagnosis. We tabulated descriptive characteristics and the positive predictive value (PPV) for a subset of the visits with available medical record review.
RESULTS: 1,619 visits with the GBS ICD-9 code were identified from 50,290,898 person-years of observation. After considering the PPV (55%) for record-reviewed visits, the age-standardized incidence rate was approximately 1.72/100,000 person-years. The rate was 40% higher for males and increased by 50% for every 10-year increase in age. The rate was 15% higher in winter and spring compared with summer. Rates were higher in more recent years.
CONCLUSIONS: GBS rates are higher in males and increase considerably with age. The potential reasons for differences in rates by season and the increased rates in more recent years should be further investigated.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22846726     DOI: 10.1159/000339248

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  16 in total

Review 1.  Deaths following vaccination: What does the evidence show?

Authors:  Elaine R Miller; Pedro L Moro; Maria Cano; Tom T Shimabukuro
Journal:  Vaccine       Date:  2015-05-23       Impact factor: 3.641

2.  Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic.

Authors:  Claudia Vellozzi; Shahed Iqbal; Brock Stewart; Jerome Tokars; Frank DeStefano
Journal:  Am J Public Health       Date:  2014-02-13       Impact factor: 9.308

3.  Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink.

Authors:  Kayla E Hanson; Kristin Goddard; Ned Lewis; Bruce Fireman; Tanya R Myers; Nandini Bakshi; Eric Weintraub; James G Donahue; Jennifer C Nelson; Stan Xu; Jason M Glanz; Joshua T B Williams; Jonathan D Alpern; Nicola P Klein
Journal:  JAMA Netw Open       Date:  2022-04-01

4.  Risk of Guillain-Barré syndrome following herpes zoster, United States, 2010-2018.

Authors:  Tara C Anderson; Jessica W Leung; Rafael Harpaz; Kathleen L Dooling
Journal:  Hum Vaccin Immunother       Date:  2021-12-02       Impact factor: 3.452

5.  Guillain-Barré Syndrome and Human Immunodeficiency Virus.

Authors:  Nermin Kelebek Girgin; Remzi İşçimen; Emel Yılmaz; Ş Ferda Kahveci; Oya Kutlay
Journal:  Turk J Anaesthesiol Reanim       Date:  2013-06-14

6.  Guillain-Barré syndrome and antecedent cytomegalovirus infection, USA 2009-2015.

Authors:  Jessica Leung; James J Sejvar; Jesus Soares; Tatiana M Lanzieri
Journal:  Neurol Sci       Date:  2019-12-11       Impact factor: 3.307

Review 7.  Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?

Authors:  Maria Vadalà; Dimitri Poddighe; Carmen Laurino; Beniamino Palmieri
Journal:  EPMA J       Date:  2017-07-20       Impact factor: 6.543

8.  Impact of the birth's season on the development of celiac disease in Italy.

Authors:  Teresa Capriati; Ruggiero Francavilla; Stefania Castellaneta; Francesca Ferretti; Antonella Diamanti
Journal:  Eur J Pediatr       Date:  2015-07-05       Impact factor: 3.183

9.  Clinical Heterogeneity of Guillain-Barré Syndrome in the Emergency Department: Impact on Clinical Outcome.

Authors:  Athanasios Papathanasiou; Ioannis Markakis
Journal:  Case Rep Emerg Med       Date:  2016-09-27

10.  Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011.

Authors:  Sharon K Greene; Melisa D Rett; Claudia Vellozzi; Lingling Li; Martin Kulldorff; S Michael Marcy; Matthew F Daley; Edward A Belongia; Roger Baxter; Bruce H Fireman; Michael L Jackson; Saad B Omer; James D Nordin; Robert Jin; Eric S Weintraub; Vinutha Vijayadeva; Grace M Lee
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.